? ? ? 西安慧康企業(yè)運營管理集團有限公司(簡稱:慧康集團)成立于2012年?;劭导瘓F以生物科技、美容連鎖為核心業(yè)務(wù)集群,構(gòu)建全產(chǎn)業(yè)鏈?zhǔn)降膰H化企業(yè)運營體系,塑造生物科技應(yīng)用于社會生活的核心價值。
? ? ? ?慧康集團將商業(yè)實踐與社會價值相融合,追求新產(chǎn)業(yè)時代下的可持續(xù)發(fā)展,斥資5.2億元建設(shè)的生物科技產(chǎn)業(yè)園區(qū),占地40畝,總建筑面積6.5萬平方米,將科研、管理、培訓(xùn)、生產(chǎn)集于一體。截至2024年10月,慧康集團旗下子公司共有166項專利,包括國家發(fā)明專利88項、外觀專利18項、實用新型專利29項,中國香港專利17項、國際專利14項;現(xiàn)有國家I類新藥1項,醫(yī)療器械2項,西安市博士后創(chuàng)新基地項目3項,重點科研項目13項。
? ? ? ?陜西慧康生物科技有限責(zé)任公司發(fā)起的“慧康?中國肽庫”項目(簡稱“中國肽庫”),將建立蛋白與多肽原料研發(fā)與供應(yīng)基地,搶占“藍(lán)海戰(zhàn)略”引領(lǐng)下的價值創(chuàng)新高地。
HuiKang Culture
生物科技進化人類生活。
共創(chuàng)、共享、共贏
為員工謀福利,為企業(yè)創(chuàng)價值,為社會做貢獻。
知行合一,敬天愛人。
以人為本、以德為先、機會均等、任賢使能。
2023?
The product ecosystem encompasses innovative drugs, biomedicine, medical devices, and high-tech biological skincare products, presenting a comprehensive range.
2022?
The sales revenue of new raw material-based skincare products in the daily chemical industry has achieved a new breakthrough.
2021?
Huikang Bio-Tech was the only Chinese enterprise in the new material group of the Global Top 100 Innovative list.
2021?
Huikang Bio-Tech was subsidize by the State Key Laboratory of Mechanical Behavior of Materials, Ministry of Education.
2021?
HuiKang Novel Coronavirus blocking peptide project obtained class I fund of Postdoctoral Innovation Base.
2020?
Argireline Serum received the honor of Shaanxi Key New Products.
2020?
The scientific achievements of collagen have been published in famous academic journal International Journal of Biological Macromolecules.
2020?
The brand ACTII was born.
2019?
HuiKang Biotechnology Industrial Park officially put into operation.
2018?
Successfully hosted the International Protein and Peptides Conference, a sub forum of the 2018 Global Hard and Core Conference and the Belt and Road Innovation conference.
2018?
Introduction article of HuiKang ? China Peptide Bank published in the sub Journal of Nature.
?2017
Launched the Phase I Construction Plan of HuiKang? China Peptide Bank.
?2017
Started Bio-tech cosmetics business.
?2017
The bio-tech cosmetics brand Ye New Skin was debuted.
?2016
Initiate the R&D of two national class I new drugs.
?2012
Xi 'an HuiKang Enterprise Operation Management Group Co., LTD was founded.
?2012
Obtained the first national invention patent.
?2011
HuiKang Biotechnology Industrial Park broke groud and started building.
?2011
A series of skin care products with protein and peptides as the core ingredients have came out after one and another..
?2011
Recombinant human collagen was successfully developed..
?2010
HuiKang R&D Center was set up.
?2001
Shaanxi Dongda Biochemical Technology Co., LTD. (the predecessor of HuiKang Bio-Tech) was established.
截至2024年10月,慧康集團旗下子公司共有166項專利,包括國家發(fā)明專利88項、外觀專利18項、實用新型專利29項,中國香港專利17項、國際專利14項。
投資5.2億元,占地40畝,建筑面積6.5萬平方米。
合成多肽中試放大系統(tǒng)
蛋白多肽制劑中試放大生產(chǎn)系統(tǒng)
重組蛋白中試放大生產(chǎn)系統(tǒng)
“中國肽庫”項目計劃構(gòu)建一個序列精準(zhǔn)的商業(yè)肽庫,或稱平行肽庫,共計超過175000條肽,未來將成為人類共享的寶庫。
?
?
?
Copyright ? 2017 慧康集團保留所有權(quán)利/
陜ICP備17008662號-1友情鏈接:
慧康生物研發(fā)中心